Your browser doesn't support javascript.
loading
Radical cancer treatment is safe during COVID-19: the real-world experience of a large London-based Comprehensive Cancer Centre during the first wave.
Russell, Beth; Moss, Charlotte; Monroy-Iglesias, Maria; Roberts, Graham; Dickinson, Harvey; Haire, Kate; Innes, Kathryn; Mulji-Shah, Bansi; Castell, Fiona; Al-Salihi, Omar; Lei, Mary; Francis, Angela; Dann, Bill; Jogia, Vikash; Hamid, Hisham; Challacombe, Ben; Simo, Ricard; Fraser, Stephanie; Gousis, Charalampos; Sawyer, Elinor; Tsotra, Eirini; Roca, Jose; Khan, Muhammad; Josephs, Debra; Enting, Deborah; Van Hemelrijck, Mieke; Harris, Victoria; Dolly, Saoirse.
Afiliação
  • Russell B; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Moss C; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. charlotte.moss@kcl.ac.uk.
  • Monroy-Iglesias M; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Roberts G; South East London Cancer Alliance, London, UK.
  • Dickinson H; South East London Cancer Alliance, London, UK.
  • Haire K; South East London Cancer Alliance, London, UK.
  • Innes K; Cancer Informatics and Data, Guy's and St. Thomas NHS Foundation Trust, London, UK.
  • Mulji-Shah B; Cancer Informatics and Data, Guy's and St. Thomas NHS Foundation Trust, London, UK.
  • Castell F; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK.
  • Al-Salihi O; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK.
  • Lei M; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK.
  • Francis A; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK.
  • Dann B; Cancer Informatics and Data, Guy's and St. Thomas NHS Foundation Trust, London, UK.
  • Jogia V; Cancer Informatics and Data, Guy's and St. Thomas NHS Foundation Trust, London, UK.
  • Hamid H; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK.
  • Challacombe B; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK.
  • Simo R; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK.
  • Fraser S; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK.
  • Gousis C; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK.
  • Sawyer E; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK.
  • Tsotra E; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK.
  • Roca J; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK.
  • Khan M; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK.
  • Josephs D; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK.
  • Enting D; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK.
  • Van Hemelrijck M; Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Harris V; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK.
  • Dolly S; Guy's Cancer, Guy's and St. Thomas NHS Foundation Trust, London, UK.
Br J Cancer ; 127(7): 1289-1295, 2022 10.
Article em En | MEDLINE | ID: mdl-35840733

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Br J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Br J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido